SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-019788
Filing Date
2022-08-10
Accepted
2022-08-10 16:06:23
Documents
60
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20220630_10q.htm   iXBRL 10-Q 700526
2 EXHIBIT 31.1 ex_405706.htm EX-31.1 11093
3 EXHIBIT 31.2 ex_405707.htm EX-31.2 11279
4 EXHIBIT 32.1 ex_405708.htm EX-32.1 4181
5 EXHIBIT 32.2 ex_405709.htm EX-32.2 4189
  Complete submission text file 0001437749-22-019788.txt   3893194

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcda-20220630.xsd EX-101.SCH 43450
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20220630_cal.xml EX-101.CAL 30245
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20220630_def.xml EX-101.DEF 255419
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20220630_lab.xml EX-101.LAB 252523
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20220630_pre.xml EX-101.PRE 285174
54 EXTRACTED XBRL INSTANCE DOCUMENT bcda20220630_10q_htm.xml XML 550765
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 221151830
SIC: 2836 Biological Products, (No Diagnostic Substances)